Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3655073
Max Phase: Preclinical
Molecular Formula: C35H44FN3O2S
Molecular Weight: 589.82
Molecule Type: Small molecule
Associated Items:
ID: ALA3655073
Max Phase: Preclinical
Molecular Formula: C35H44FN3O2S
Molecular Weight: 589.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)c1ccc(C2(N3CCc4cc(S(=O)(=O)Nc5ccc(CCCC6CCCC6)cc5F)ccc4C3)CC2)cn1
Standard InChI: InChI=1S/C35H44FN3O2S/c1-34(2,3)33-16-13-29(23-37-33)35(18-19-35)39-20-17-27-22-30(14-12-28(27)24-39)42(40,41)38-32-15-11-26(21-31(32)36)10-6-9-25-7-4-5-8-25/h11-16,21-23,25,38H,4-10,17-20,24H2,1-3H3
Standard InChI Key: YZPKLDOKHZNBNU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 589.82 | Molecular Weight (Monoisotopic): 589.3138 | AlogP: 7.88 | #Rotatable Bonds: 9 |
Polar Surface Area: 62.30 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.55 | CX Basic pKa: 6.38 | CX LogP: 8.42 | CX LogD: 8.35 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.28 | Np Likeness Score: -0.89 |
1. (2015) Nitrogen-containing condensed heterocyclic compound, |
Source(1):